BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37742328)

  • 1. Randomized trial to assess the potential role of ascorbic acid and statin for post-contrast acute kidney injury prevention.
    Hashem A; Laymon M; Elgamal M; Hegazy M; Elmeniar AM; Refaie H; Osman Y
    Int Urol Nephrol; 2024 Feb; 56(2):399-405. PubMed ID: 37742328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-Dose Perioperative Atorvastatin and Acute Kidney Injury Following Cardiac Surgery: A Randomized Clinical Trial.
    Billings FT; Hendricks PA; Schildcrout JS; Shi Y; Petracek MR; Byrne JG; Brown NJ
    JAMA; 2016 Mar; 315(9):877-88. PubMed ID: 26906014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
    Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
    J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the preventive efficacy of rosuvastatin versus atorvastatin in post-contrast acute kidney injury in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.
    Dai Y; Huang J; Zeng L; Huang Z; Duan C; Shao S; Chen H; Xue L; Chen J; Tan N; He P; Liu Y; Yu D
    Biomed Pharmacother; 2020 Aug; 128():110336. PubMed ID: 32521452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of Short-Term Statin Treatment for the Prevention of Contrast-Induced Acute Kidney Injury in Patients Undergoing Coronary Angiography/Percutaneous Coronary Intervention: A Meta-Analysis of 21 Randomized Controlled Trials.
    Li H; Wang C; Liu C; Li R; Zou M; Cheng G
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):201-19. PubMed ID: 26899537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative Effectiveness of 12 Treatment Strategies for Preventing Contrast-Induced Acute Kidney Injury: A Systematic Review and Bayesian Network Meta-analysis.
    Su X; Xie X; Liu L; Lv J; Song F; Perkovic V; Zhang H
    Am J Kidney Dis; 2017 Jan; 69(1):69-77. PubMed ID: 27707552
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HMG CoA reductase inhibitors (statins) for preventing acute kidney injury after surgical procedures requiring cardiac bypass.
    Lewicki M; Ng I; Schneider AG
    Cochrane Database Syst Rev; 2015 Mar; 2015(3):CD010480. PubMed ID: 25758322
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylactic atorvastatin prior to intra-arterial administration of iodinated contrast media for prevention of contrast-induced acute kidney injury: A meta-analysis of randomized trial data
.
    Sun YY; Liu LY; Sun T; Wu MY; Ma FZ
    Clin Nephrol; 2019 Sep; 92(3):123-130. PubMed ID: 31347493
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statins and Incidence of Contrast-Induced Acute Kidney Injury Following Coronary Angiography - Five Year Experience at a Tertiary Care Center.
    Sreenivasan J; Khan MS; Li H; Zhuo M; Patel A; Fugar S; Tarbutton M; Siddamsetti S; Yadav N
    Cardiovasc Revasc Med; 2019 Aug; 20(8):654-658. PubMed ID: 30318173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of statins on post-contrast acute kidney injury: a multicenter retrospective observational study.
    Lin M; Xu T; Zhang W; Li D; Li Y; Hong X; Luan Y; Zhang W; Wang M
    Lipids Health Dis; 2021 Jul; 20(1):63. PubMed ID: 34225750
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Prospective, Randomized, Open-Label Trial of Atorvastatin versus Rosuvastatin in the Prevention of Contrast-Induced Acute Kidney Injury, Worsened Renal Function at 30 Days, and Clinical Events After Acute Coronary Angiography: the PRATO-ACS-2 Study.
    Toso A; Leoncini M; Maioli M; Tropeano F; Villani S; Bellandi F
    Cardiorenal Med; 2020; 10(5):288-301. PubMed ID: 32434204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The atorvastatin effects on the prevention of contrast-induced acute kidney injury during computed tomography with contrast media].
    Vasin AA; Mironova OI; Fomin VV
    Ter Arkh; 2022 Oct; 94(9):1057-1061. PubMed ID: 36286755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early high-dose rosuvastatin for contrast-induced nephropathy prevention in acute coronary syndrome: Results from the PRATO-ACS Study (Protective Effect of Rosuvastatin and Antiplatelet Therapy On contrast-induced acute kidney injury and myocardial damage in patients with Acute Coronary Syndrome).
    Leoncini M; Toso A; Maioli M; Tropeano F; Villani S; Bellandi F
    J Am Coll Cardiol; 2014 Jan 7-14; 63(1):71-9. PubMed ID: 24076283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of high loading dose of atorvastatin in diabetic patients with renal dysfunction undergoing elective percutaneous coronary intervention: a randomized controlled trial.
    Shehata M; Hamza M
    Cardiovasc Ther; 2015 Apr; 33(2):35-41. PubMed ID: 25677920
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot double-blind, randomized controlled trial of short-term atorvastatin for prevention of acute kidney injury after cardiac surgery.
    Prowle JR; Calzavacca P; Licari E; Ligabo EV; Echeverri JE; Haase M; Haase-Fielitz A; Bagshaw SM; Devarajan P; Bellomo R
    Nephrology (Carlton); 2012 Mar; 17(3):215-24. PubMed ID: 22117606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of kidney injury for patients treated with a high-potency versus moderate-potency statin regimen after an acute coronary syndrome.
    Sarma A; Cannon CP; de Lemos J; Rouleau JL; Lewis EF; Guo J; Mega JL; Sabatine MS; O'Donoghue ML
    J Am Heart Assoc; 2014 May; 3(3):e000784. PubMed ID: 24786143
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of atorvastatin on the incidence of acute kidney injury following valvular heart surgery: a randomized, placebo-controlled trial.
    Park JH; Shim JK; Song JW; Soh S; Kwak YL
    Intensive Care Med; 2016 Sep; 42(9):1398-407. PubMed ID: 27120082
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins and contrast-induced acute kidney injury with coronary angiography.
    Gandhi S; Mosleh W; Abdel-Qadir H; Farkouh ME
    Am J Med; 2014 Oct; 127(10):987-1000. PubMed ID: 24852935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preventive effect of statin pretreatment on contrast-induced acute kidney injury in patients undergoing coronary angioplasty: propensity score analysis from a multicenter registry.
    Hoshi T; Sato A; Kakefuda Y; Harunari T; Watabe H; Ojima E; Hiraya D; Abe D; Nishina H; Takeyasu N; Noguchi Y; Aonuma K
    Int J Cardiol; 2014 Feb; 171(2):243-9. PubMed ID: 24393575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Does ascorbic acid protect against contrast-induced acute kidney injury in patients undergoing coronary angiography: a systematic review with meta-analysis of randomized, controlled trials.
    Sadat U; Usman A; Gillard JH; Boyle JR
    J Am Coll Cardiol; 2013 Dec; 62(23):2167-75. PubMed ID: 23994417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.